glp 1 gip receptor agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research LY3437943, a novel triple glucagon,
Description
Weight loss head-to-head Retatrutide at 12mg produced approximately 24% body weight loss at 48 weeks
Both of these innovations are on the market already
Teede et al
doi: 10.1016/j.metabol.2019.154045
The result is gas buildup in the upper GI tract that gets released as sulfur-scented burps, sometimes accompanied by a feeling of bloating, nausea, or general stomach discomfort that many people notice early in treatment
